Korean J Fam Med Search

CLOSE


Korean J Fam Med > Volume 30(11); 2009 > Article
Korean Journal of Family Medicine 2009;30(11):843-847.
DOI: https://doi.org/10.4082/kjfm.2009.30.11.843    Published online November 20, 2009.
Diagnosis and Management of Novel Influenza A (H1N1).
Seong Heon Wie, Woo Joo Kim
1Department of Internal Medicine, The Catholic University of Korea College of Medicine, Seoul, Korea.
2Department of Internal Medicine, Korea University College of Medicine, Seoul, Korea. wjkim@korea.ac.kr
신종 인플루엔자 A (H1N1)의 진단과 치료
위성헌, 김우주
1
2
Abstract
Since the World Health Organization has offi cially declared a global infl uenza pandemic, the number of human cases of pandemic infl uenza A (H1N1) in 2009 has been increasing in many countries. Especially from mid-October, the number of domestic cases of infl uenza A (H1N1) has been exponentially increasing, with the number of confi rmed cases reaching over 100,000. The clinical symptoms of novel infl uenza A (H1N1) include fever, cough, sore throat, runny nose, myalgia, headache, chills and fatigue. Nucleic acid amplification tests, including real time RT-PCR assay specific for 2009 novel influenza A (H1N1) can be used in the patients with suspected influenza. Antiviral treatment by using neuraminidase inhibitors (oseltamivir, zanamivir) is recommended by Centers for Disease Control and Prevention for treatment of novel influenza A (H1N1) disease. Personal and public efforts to control the outbreak of novel influenza A (H1N1) disease are required. Vaccination against pandemic H1N1 is important for personal health, but also to build community-level immunity to novel infl uenza A.
Key Words: Novel Infl uenza A (H1N1); Oseltamivir; Zanamivir


ABOUT
ARTICLE CATEGORY

Browse all articles >

BROWSE ARTICLES
INFORMATION FOR AUTHORS AND REVIEWERS
Editorial Office
Room 2003, Gwanghwamun Officia, 92 Saemunan-ro, Jongno-gu, Seoul 03186, Korea
Tel: +82-2-3210-1537    Tax: +82-2-3210-1538    E-mail: kjfm@kafm.or.kr                

Copyright © 2022 by Korean Academy of Family Medicine.

Developed in M2PI

Close layer
prev next